NEJM publishes final results from phase two study showing vaccines can reduce rate of sustained TB infections
ROCKVILLE, MARYLAND (JULY 11, 2018) --Aeras, a nonprofit organization dedicated to developing vaccines against tuberculosis (TB), today announced the publication of the full results from...








